홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

6-Fluoro-5-methylpyridine-3-carboxylic acid → [4-(3,5-Dimethylpyridin-2-yl)piperazin-1-yl](6-fluoro-5-methylpyridin-3-yl)methanone

HRID 1804100
인쇄

반응식

HRID 1804100 반응식
[F:1][C:2]1[C:10]([CH3:11])=[CH:9][C:5]([C:6]([OH:8])=O)=[CH:4][N:3]=1.[CH3:12][C:13]1[C:14]([N:20]2[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]2)=[N:15][CH:16]=[C:17]([CH3:19])[CH:18]=1>>[CH3:12][C:13]1[C:14]([N:20]2[CH2:21][CH2:22][N:23]([C:6]([C:5]3[CH:4]=[N:3][C:2]([F:1])=[C:10]([CH3:11])[CH:9]=3)=[O:8])[CH2:24][CH2:25]2)=[N:15][CH:16]=[C:17]([CH3:19])[CH:18]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 164142236-Fluoro-5-methylpyridine-3-carboxylic acidHCID 584844961-(3,5-Dimethylpyridin-2-yl)piperazine

생성물 1

HCID 58484665[4-(3,5-Dimethylpyridin-2-yl)piperazin-1-yl](6-fluoro-5-methylpyridin-3-yl)methanone수율 103.9%

실험 절차

By reaction and treatment in the same manner as in Preparation Example 60 and using 6-fluoro-5-methylnicotinic acid (500 mg) and 1-(3,5-dimethylpyridin-2-yl)piperazine (620 mg) described in Preparation Example 47, the title compound (1.1 g) was obtained.

후처리

  1. customBy reaction and treatment in the same manner
  2. customas in Preparation Example 60
  • customdescribed in Preparation Example 47
  • 출처 및 근거

    ORD 기록
    ord-4470b9ab8f704a2ab03654eaedf92f33
    출처 데이터셋
    uspto-grants-2013_01
    DOI
    10.6084/m9.figshare.5104873.v1
    특허 번호
    US08354401B2

    반응 노트

    이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트